Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MyMAP for Nicotine Dependence Treatment
NCT02136498Completed
- Sponsor
- Kaiser Permanente
- Start
- Oct 2014
- Primary completion
- Feb 2016
- Countries
- 1
01
Overview
Randomised, open-label trial in nicotine dependence (2 arms), sponsored by Kaiser Permanente. Primary endpoint: Point Prevalence Abstinence at 5 months. Started Oct 2014; status: completed.
02
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02136498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02136498.